China quietly became biotech’s back-office, from molecule synthesis and clinical trials to novel drug licensing. Now the ...

A research team led by the University of Oxford's Department of Engineering Science has shown it is possible to engineer a ...

Just when you had written off biotech stocks as boring, here comes the MIT Technology Review to name its “Three technologies ...

Quantum physics is no longer confined to cryogenic chips and vacuum chambers. It is starting to seep into the machinery of ...

The company made an even more dramatic claim the following month, when it announced it had created three dire wolves. These ...

So far this month, investors have poured $2.6 billion into follow-on rounds for public biotechs — the most ever for the ...

The biotech sector is one that’s become red-hot, at least in recent years. After around a decade of stagnation, investors ...

Venture capitalists point to a surge in M&A and a glint of revival in the IPO arena as signs of better days ahead.

Shares of biotech companies were outpacing the broader market on Thursday. The State Street SPDR S&P Biotech ETF was up 2.7%, compared with the 0.8% gain of the S&P 500. A significant portion of these ...

Stay updated on biotech layoffs in 2026! Each week, we track and analyze industry layoffs, their causes, and their impact.

At some point in your research career, you may find yourself transitioning from academia to industry or vice versa. To best set yourself up for success, adapt your approach to the specific scientific ...

Benzinga tracks 150 analyst firms and reports on their stock expectations. Analysts typically arrive at their conclusions by ...